How Does Semaglutide Work? GLP-1 Explained Simply

Semaglutide works by activating GLP-1 receptors, which are involved in regulating appetite, calorie intake, blood glucose and gastric emptying.

It does not simply “burn fat.” Instead, semaglutide mimics the activity of a naturally occurring hormone called glucagon-like peptide-1, or GLP-1, and activates GLP-1 receptors in several parts of the body.

According to the current U.S. FDA prescribing information, semaglutide has approximately 94% sequence homology to human GLP-1 and selectively binds to and activates the GLP-1 receptor. These receptors are present in several brain regions involved in appetite regulation.

Understanding this pathway helps explain why semaglutide can influence hunger, food intake and body weight.

What Is GLP-1?

GLP-1 is a naturally occurring hormone involved in appetite regulation, calorie intake and glucose control.

Semaglutide belongs to a class of medicines known as GLP-1 receptor agonists. Rather than directly breaking down body fat, it activates the same receptor targeted by natural GLP-1.

The FDA describes GLP-1 as a physiological regulator of both appetite and caloric intake. GLP-1 receptors are found in several areas of the brain involved in regulating food intake.

For weight management, three effects are especially useful for understanding the mechanism:

These effects occur through related GLP-1 pathways rather than through a direct “fat-burning” action.

How Does Semaglutide Affect Appetite?

The weight-management effect of semaglutide appears to be driven largely by changes in appetite and calorie intake.

The FDA prescribing information states that semaglutide decreases calorie intake and that its effects on body weight are likely mediated by effects on appetite.

The European Medicines Agency similarly explains that semaglutide acts on GLP-1 receptors involved in hunger regulation, which can increase feelings of fullness while reducing hunger and food intake.

In practical terms, this means semaglutide does not need to directly “burn” stored fat. Reduced energy intake over time can contribute to changes in body weight.

Does Semaglutide Slow Digestion?

Semaglutide delays gastric emptying, meaning food can remain in the stomach for longer before moving into the intestine.

This is one part of its pharmacological effect, although gastric emptying should not be treated as the sole explanation for weight reduction. Appetite regulation and reduced calorie intake are also important parts of the mechanism.

Delayed gastric emptying also has safety implications because it may affect the absorption of certain oral medicines.

What Does Semaglutide Do to Insulin and Glucagon?

Semaglutide affects insulin and glucagon in a glucose-dependent manner.

According to FDA prescribing information, semaglutide stimulates insulin secretion and reduces glucagon secretion when glucose levels are elevated.

These actions can contribute to improved blood-glucose regulation.

Different semaglutide products may have different formulations, doses and approved indications, so they should not automatically be treated as interchangeable.

So How Can Semaglutide Lead to Weight Loss?

Semaglutide can support weight reduction primarily by influencing appetite and reducing calorie intake over time.

The mechanism can be summarized simply:

Semaglutide → GLP-1 receptor activation → appetite regulation → lower calorie intake → body-weight reduction over time

The FDA prescribing information reports that weight reduction with semaglutide involves greater reduction in fat mass than lean mass, although both may decrease.

Individual responses vary according to treatment duration, dose, medical conditions and other factors.

What Did Clinical Trials Show?

Clinical trials demonstrated meaningful average weight reduction in selected populations, but individual results vary.

In the phase 3 STEP 1 trial, 1,961 adults with obesity, or overweight plus at least one weight-related condition, were randomized to once-weekly semaglutide 2.4 mg or placebo for 68 weeks.

At week 68, mean body-weight change was approximately −14.9% with semaglutide versus −2.4% with placebo.

These figures represent trial averages and should not be interpreted as a guaranteed individual outcome.

Gastrointestinal adverse events, including nausea and diarrhea, were among the most commonly reported side effects.

Injectable vs. Oral Semaglutide

Injectable and oral semaglutide act through the same GLP-1 receptor pathway, but absorption, administration and approved indications can differ.

Semaglutide products should therefore be evaluated according to the specific formulation, product label and regulatory approval in each country.

Patients should follow the administration instructions provided for the specific prescribed product.

Benefits and Limitations

Semaglutide targets biological pathways involved in appetite and food intake, but treatment benefits must always be considered together with potential risks.

Clinical trials have shown significant average weight reduction in certain patient populations when semaglutide was combined with lifestyle intervention.

However, commonly reported adverse reactions include gastrointestinal symptoms such as:

• Nausea
• Diarrhea
• Vomiting
• Constipation
• Abdominal discomfort

More serious adverse reactions and contraindications are described in official prescribing information.

Semaglutide-containing prescription products should only be used under appropriate medical supervision.

Frequently Asked Questions

How does semaglutide work for weight loss?

Semaglutide activates GLP-1 receptors involved in appetite and calorie-intake regulation. Its effects on body weight are thought to occur primarily through reduced appetite and calorie intake.

Does semaglutide burn fat directly?

Semaglutide is not classified as a direct fat-burning drug. Its primary mechanism involves GLP-1 receptor activation, appetite regulation and reduced calorie intake.

Does semaglutide make you feel less hungry?

Semaglutide can influence brain pathways involved in appetite and satiety. In clinical studies, many participants experienced reduced hunger and food intake, although individual responses vary.

Does semaglutide slow the stomach?

Yes. Semaglutide delays gastric emptying. This is one component of its pharmacological effect and may also contribute to gastrointestinal side effects.

Is oral semaglutide the same as injectable semaglutide?

They contain semaglutide and act on the same GLP-1 receptor, but their dosing, absorption, administration instructions and approved indications may differ.

What are the most common semaglutide side effects?

Commonly reported adverse effects include nausea, diarrhea, vomiting, constipation and abdominal discomfort. Patients should review the prescribing information and discuss individual risks with a healthcare professional.

Is semaglutide approved for weight management everywhere?

No. Regulatory approval, formulations and indications differ by country and can change over time. Local regulatory information should always be checked.

Should I consult a doctor before using semaglutide?

Yes. Semaglutide is a prescription medicine and requires appropriate medical assessment, prescription and monitoring by a licensed healthcare professional.

Key Takeaway

Semaglutide does not simply “burn fat.” It activates GLP-1 receptors that influence appetite, calorie intake, gastric emptying and glucose regulation.

For weight management, one of the most important effects is reduced appetite and calorie intake over time.

Clinical trials have demonstrated significant average weight reduction in selected populations, but individual outcomes vary and potential adverse effects must also be considered.

References

1. U.S. Food and Drug Administration. Wegovy (semaglutide) Prescribing Information.
2. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021;384:989–1002.
3. European Medicines Agency. Wegovy EPAR.

Disclaimer

This content is for general educational purposes only and is not medical advice. Semaglutide is prescription-only and must be prescribed by a licensed healthcare professional. Approval status and availability vary by country. Always consult local regulatory guidance and a qualified physician before making treatment decisions.

Regulatory status reflects information available at publication and may change; verify with the relevant authority, including the FDA, EMA, MHRA or MFDS.